Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 45 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
The CARDIOPROTECT Trial
NCT07654426
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- University of California Irvine Medical Center Orange, California, United States
- University of California (UC) Davis Sacramento, California, United States
NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
NCT06043011
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
- Praxis für Interdisziplinäre Hämatologie und Onkologie Freiburg im Breisgau, Germany
NCT04836507
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
NCT07499271
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07493148
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China
NCT07493109
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China
NCT04830137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Irvine Orange, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
NCT07473167
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma (HGBL), +14 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT07397832
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Tianjin Medical University Cancer Insititute & Hospital Tianjin, Tianjin Municipality, China
NCT07189065
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
- Beijing Shijitan Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
- National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
NCT07084662
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Wilmot Cancer Institute Rochester, New York, United States
NCT07078500
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT03936153
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- China-Japan Friendship Hospital Beijing, China
- Peking University Third Hospital Beijing, China
- West China Hospital, Sichuan University Chengdu, China
NCT06832228
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China